GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company. The Company is focused on developing and commercializing its eSensor detection technology. The Companys electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. The Companys XT-8 system received 510(k) clearance from the United States Food and Drug Administration (FDA) and is designed to support a range of molecular diagnostic tests with workstation and self-contained, disposable test cartridges. The Company also developed two hepatitis C virus (HCV), genotyping tests, a 3A4/3A5 genotyping test and a 2C19 genotyping test, versions of which are available for research use only (RUO). The Companys products include XT-8 System, XT-8 Test Menu, Vitro Diagnostic (IVD) Test Menu and Research Use Only (RUO) Test Menu. The Companys technologies include XT-8 eSensor Technology, XT-8 Test Cartridges and XT-8 Workstation.